Tiziana life sciences plc files scheme of arrangement to effect a corporate reorganisation and, if approved, the delisting of its ordinary shares in london and the direct listing of common shares in the new parent company of the tiziana group on nasdaq

London and new york, aug. 20, 2021 (globe newswire) -- tiziana life sciences plc (nasdaq: tlsa / lse: tils) ("old tiziana") a biotechnology company focused on innovative therapeutics for oncology, inflammation, and infectious diseases today announces that it has formally commenced its strategic plan to change its corporate structure by establishing tiziana life sciences ltd (“new tiziana”), a bermuda-incorporated company, as the ultimate parent company of the of the tiziana group. the reorganisation will be achieved by a scheme of arrangement under part 26 of the companies act 2006 (the "scheme").
TLSA Ratings Summary
TLSA Quant Ranking